HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ly-364947

a TbetaR-I kinase inhibitor at a low dose in treating several experimental intractable solid tumors, including pancreatic adenocarcinoma and diffuse-type gastric cancer, characterized by hypovascularity and thick fibrosis in tumor microenvironments
Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ezura, Yoichi: 1 article (02/2015)
2. Noda, Masaki: 1 article (02/2015)
3. Hayata, Tadayoshi: 1 article (02/2015)
4. Nishinakamura, Ryuichi: 1 article (02/2015)
5. Asashima, Makoto: 1 article (02/2015)
6. Yoichi, Ezura: 1 article (02/2015)
7. Lüke, Matthias: 1 article (06/2014)
8. Grisanti, Salvatore: 1 article (06/2014)
9. Soliman, Mahmoud: 1 article (06/2014)
10. Tura, Aysegul: 1 article (06/2014)

Related Diseases

1. Pancreatic Neoplasms (Pancreatic Cancer)
2. Neoplasms (Cancer)
3. Proliferative Vitreoretinopathy
4. Cicatrix (Scar)
5. Congenital Abnormalities (Deformity)

Related Drugs and Biologics

1. Collagen
2. gemcitabine
3. Phosphotransferases (Kinase)